Bay­er's re­struc­tur­ing hits phar­ma lead­er­ship, shift­ing about half of ex­ecs off top team

Bay­er is “ba­si­cal­ly halv­ing” the size of its phar­ma­ceu­ti­cal lead­er­ship team, a spokesper­son told End­points News, as the com­pa­ny be­gins to roll out a re­struc­tur­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER